Summary

The product Anadrol 25 mg, manufactured by MusclaCandy, was tested to verify its potency and authenticity. The sample, identified by batch number Lot1008, was submitted by the manufacturer MuscleCandy (labs@musclecandy.net) and analyzed by Janoshik Analytical. The analysis revealed an Oxymetholone concentration of 21.62 mg per tablet, slightly below the labeled claim of 25 mg by 13.52%.

The testing process began on 19 July 2024, with the sample received on 29 July 2024, and analysis completed on 5 August 2024. The results indicate a noticeable variance below the label claim, which may indicate potential quality control issues during manufacturing.


Detailed Report

Product Overview

Sample Acquisition and Testing

Testing Results


Verification Details


Evaluation of Manufacturer-Submitted Testing

The measured concentration of Oxymetholone indicates a deviation from the label claim, suggesting potential inconsistencies in manufacturing or degradation during storage. Although the product remains potent, its deviation from the stated dosage could impact effectiveness.


Conclusion

The analysis confirms that the tested batch of Anadrol 25 mg contains 21.62 mg of Oxymetholone per tablet, representing a significant deviation of -13.52% from the label claim. This discrepancy highlights the need for caution and further independent testing to assess the consistency and quality of future production runs.


Disclaimer

This report is intended for educational and harm-reduction purposes. Manufacturer-submitted testing can provide valuable insights but may reflect selective sampling. Consumers are encouraged to make informed decisions and consider further independent analysis.